Greater China
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
2022 preview: SaaS
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
China supermarket chain T11 raises $100m
T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.
Q&A: Legend Capital's Richard Li
Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits
Deal focus: Longreach eyes long overdue EnTie exit
Mindful of how political maneuvering has undone previous sale processes of Taiwan’s EnTie Commercial Bank, The Longreach Group is on edge as regulators prepare to rule on a $1.2 billion tie-up with IBF Financial
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
China's Avistone Pharmaceuticals raises $200m
Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.
Biotech player CANbridge drops on debut after $87m HK IPO
CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses on treatments for cancer and rare diseases, lost 27% in value on its Hong Kong trading debut following a HK$685.1 million ($87.8 million) IPO.
Blue Owl buys Asia-based placement agent
US alternative asset manager Blue Owl Capital has acquired Hong Kong placement agent Ascentium with a view to establishing a physical presence in the territory and pursuing a broader regional expansion.
China’s ABclonal Technology raises $189m
Chinese life science research and diagnostic reagents provider ABclonal Technology has raised a RMB1.2 billion ($189 million) Series D round featuring Sequoia Capital China.
Jardine Matheson leads $37m round for Hong Kong's Pickupp
Jardine Matheson has led a $37 million Series B round for Hong Kong-based package delivery start-up Pickupp.
L Catterton backs China-based Amazon vendor aggregator
Nebula Brands, a China-based aggregator of Amazon vendors, has raised $50 million in Series B funding led by L Catterton Asia.
HarbourVest hires Allianz executive for China institutional busines
HarbourVest Partners has recruited Cicely Sun from Allianz Global Investors as a managing director and co-head of its Beijing office.
Navis sells Asia inspection business to CDPQ
Navis Capital Partners has sold its minority interest in Qima, an Asia-focused testing, inspection, and certification (TIC) business to Caisse de dépôt et placement du Québec (CDPQ), following a four-year holding period.
China's SenseTime plans pared back Hong Kong IPO
Chinese artificial intelligence (AI) technology developer SenseTime is looking to raise up to HK$5.99 billion in a Hong Kong IPO that is considerably smaller than originally envisaged.
Fund focus: Lightspeed bets on green-tech
Green-tech is the latest big idea being championed by Lightspeed China Partners. It has inspired a change in the firm’s name and it will underpin deployment of the new $920 million fund
Deal focus: Gaussian serves China’s aged
With its globally competitive technology and low costs, Gaussian Robotics has become a dominant force in the cleaning robot segment. SoftBank Vision Fund is the latest addition to its cap table
Asia exits: Pass the parcel
Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk
China surgical robotics player RainMed raises $100m
Ping An Capital has led a Series D round of approximately $100 million for RainMed Medical, a China-based surgical robotics business. Other investors include Seresia Asset Management and Lighthouse Canton.
Longreach to exit Taiwan bank after 14-year hold
The Longreach Group has agreed to sell Taiwan’s EnTie Commercial Bank to IBF Financial Holdings for NT$33.7 billion ($1.2 billion), ending a 14-year journey marked by several frustrated exit attempts.
KKR promotes Chris Sun to partner
Chris Sun (pictured), a managing director at KKR who focuses on investments in China’s consumer sector, has been promoted to partner.
China 3D printing start-up WeNext raises $55m
Temasek Holdings, Cathay Capital Private Equity, and Haochen Capital have led a $55 million Series B round for WeNext Technology, a China-based 3D printing specialist.
CVC backs take-private of Hong Kong-listed Razer
CVC Capital Partners is supporting a proposed founder-led privatization of Hong Kong-listed gaming hardware and software provider Razer that values the business at HK$24.7 billion ($3.17 billion).
China's Didi to delist in New York
China ride-hailing platform Didi, which has traded poorly ever since being targeted by regulators in the wake of its IPO in June, plans to delist from the New York Stock Exchange and relist in Hong Kong.